Retatrutide (Triple-G): Next-Gen Weight Loss Peptide Guide for UAE (2026)
Retatrutide (Triple-G): Next-Gen Weight Loss Peptide Guide for UAE (2026)
TL;DR: Retatrutide is a triple agonist peptide (GLP-1 + GIP + glucagon) by Eli Lilly. Phase 2 trials published in the New England Journal of Medicine showed 24.2% average body weight loss at 48 weeks — surpassing both semaglutide and tirzepatide. Currently in Phase 3 trials. The most potent weight-loss compound to emerge from clinical research in a generation. Available as a research peptide in the UAE.
Shop Featured Products
Need bacteriostatic water to reconstitute this peptide?
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Related Products
CS
Written by Amir Arsalan
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
✓ Research-Based
✓ UAE Market Expert
✓ Medically Reviewed
✓ Lab-Tested Products
Last reviewed: March 2026 · About Core Sup
